[
    [
        {
            "time": "",
            "original_text": "高溢价“卖身”失败 佐力药业靠补助盈利能走多远？ 并购重组异常",
            "features": {
                "keywords": [
                    "高溢价",
                    "卖身失败",
                    "佐力药业",
                    "补助盈利",
                    "并购重组异常"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "高溢价“卖身”失败 佐力药业靠补助盈利能走多远？ 并购重组异常",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "电鳗快报|业绩持续四年下滑 佐力药业3600万元补助或迎转机 盈利能力下降",
            "features": {
                "keywords": [
                    "业绩下滑",
                    "佐力药业",
                    "补助",
                    "转机",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "电鳗快报|业绩持续四年下滑 佐力药业3600万元补助或迎转机 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "2019十大最受机构关注个股 海康威视位列首位",
            "features": {
                "keywords": [
                    "2019",
                    "机构关注",
                    "海康威视",
                    "首位"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "2019十大最受机构关注个股 海康威视位列首位",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "【民生医药|公司深度】复星医药：整合能力提升+创新增量催化，业绩迎来兑现期",
            "features": {
                "keywords": [
                    "复星医药",
                    "整合能力提升",
                    "创新增量",
                    "业绩兑现期"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【民生医药|公司深度】复星医药：整合能力提升+创新增量催化，业绩迎来兑现期",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]